Vol. 1 No. 1 (2012)

Articles

• Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Report of Three Cases with Immunohistochemical Study

  Anupam Sarma, Debabrata Barmon, J.D. Sharma, Amal Chandra Kataki, Chidananda Bhuyan

   1-4

  • PDF
• Extramedullary Plasmacytoma of the Lung - Rather a Disseminated than a Localized Disease? - A Case Report of a Primary Pulmonary Plasmacytoma Showing Distinct Signs of Systemic Spread

  Lisa Billecke, Eva Maria Murga Penas, Jozef Zustin, Thorsten Derlin, Carsten Bokemeyer, Georgia Schilling

   5-9

  • PDF
• Topical Treatment of Skin Squamous Cell Carcinoma with Potassium Dobesilate Cream

  Pedro Cuevas, Javier Angulo, Adrián Cuevas-Bourdier, Guillermo Giménez-Gallego

   10-13

  • PDF
• Moving EGFR Targeted Therapy into the Induction Phase of the Management of Squamous Cell Carcinoma of the Head and Neck

  Belisario A. Arango, Bertha E. Sanchez, Matthew C. Abramowitz, Edgardo S. Santos

   14-21

  • PDF
• Does Tumour Biological Behaviour Influence Prognosis More than Diagnostic Delay in Oral Cancer?

  Juan Manuel Seoane-Romero, Pablo Ignacio Varela-Centelles, Pedro Diz-Dios, Isabel Ramos-Barbosa, Javier Fernández Feijoo, Juan Seoane

   22-27

  • PDF
• Brain Tumor Stem Cells and Immunotherapy

  Isako Saga, Masahiro Toda

   28-38

  • PDF
• Collision Primary Tumor of the Endometrium: Large Cell Neuroendocrine Carcinoma and Endometrioid Adenocarcinoma

  Wyatt Unger, Qian Tang, Danielle Summers, Wenxin Zheng

   39-43

  • PDF
• Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients

  Julia E. Stokes, Michael S. Bobola, Marc C. Chamberlain, John R. Silber

   44-48

  • PDF
• PAX3-FKHR Regulates the Expression of Pleiotrophin to Mediate Motility in Alveolar Rhabdomyosarcoma Cells

  Lingling Liu, Taosheng Chen

   49-56

  • PDF
• Transcriptional Modulation of the ERK1/2 MAPK and NF-kB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer

  Kathryn A. Bailey, Kathleen Wallace, Lisa Smeester, Sheau-Fung Thai, Douglas C. Wolf, Stephen W. Edwards, Rebecca C. Fry

   57-68

  • PDF
• Tissue-Engineered “Metastases”: Treatment of Hepatic Colon Tumors with a Dual Action Autotaxin Inhibitor-Lysophosphatidic Acid Receptor Antagonist

  Guanghui Yang, Honglu Zhang, Glenn D. Prestwich

  69-77

  • PDF
• TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide

  Ana-Matea Mikecin, Mira Grdisa

   78-86

  • PDF
• Mobile Phone Based Healthcare Platform for Assisting Lung Cancer Prevention

  Jun Yang, Bowei Chen, Jing Liu

   87-93

  • PDF
• Present and Emerging Targeted Therapy for Metastatic Breast Cancer

  Vito Lorusso, Ilaria Marech, Marianna Giampaglia, Andrea Tinelli, Vincenzo Emanuele Chiuri

   94-101

  • PDF
• EGFR Tyrosine Kinase Inhibitors Prolong Overall Survival in EGFR Mutated Non-Small-Cell Lung Cancer Patients with Postsurgical Recurrence

  Kenichi Suda, Simon Ito, Hiroshi Mizuuchi, Yoshihiko Maehara, Yasushi Yatabe, Tetsuya Mitsudomi

   102-107

  • PDF
• Treatment of Chemotherapy - Induced Peripheral Neuropathy: The Physicians Need Guidelines, the Patients Need Help

  Krzysztof Brzezinsk

   108-113

  • PDF
• High-Expression of PTEN and an Absence of PCNA in Osteoclast-Like Multinucleated Giant Cells of Giant Cell Tumors in Bone

  Chao Lou, Rong Qiang, Hongmin Yan, Jie Li

   114-121

  • PDF
• Biological Efficacy of a Dendritic Cell-Based Vaccine in a Patient with Metastatic Colorectal Cancer

  Mario M. Soldevilla, Susana Inogés, Ascensión López-Díaz de Cerio, Fernando Pastor, Helena Villanueva, Maurizio Bendandi

   122-128

  • PDF
• Strategies of Targeting Tumors and Cancers

  Rajesh K. Sain, Raje Chouhan, Laxmi P. Bagri, A.K. Bajpa

   129-152

  • PDF